A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer

NCT00087620 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: XELODA [capecitabine]

Sponsor

Hoffmann-La Roche